Voloridge Investment Management LLC Buys Shares of 576,369 Haleon plc (NYSE:HLN)

Voloridge Investment Management LLC acquired a new stake in Haleon plc (NYSE:HLN - Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 576,369 shares of the company's stock, valued at approximately $5,499,000.

Several other institutional investors and hedge funds have also made changes to their positions in the stock. FMR LLC boosted its holdings in shares of Haleon by 3.7% in the fourth quarter. FMR LLC now owns 108,827,814 shares of the company's stock valued at $1,038,217,000 after acquiring an additional 3,909,545 shares in the last quarter. Wellington Management Group LLP boosted its holdings in shares of Haleon by 67.5% in the fourth quarter. Wellington Management Group LLP now owns 15,328,325 shares of the company's stock valued at $146,232,000 after acquiring an additional 6,175,835 shares in the last quarter. Envestnet Asset Management Inc. boosted its holdings in shares of Haleon by 0.8% in the fourth quarter. Envestnet Asset Management Inc. now owns 7,630,307 shares of the company's stock valued at $72,793,000 after acquiring an additional 58,444 shares in the last quarter. JPMorgan Chase & Co. boosted its holdings in shares of Haleon by 18.3% in the fourth quarter. JPMorgan Chase & Co. now owns 6,014,903 shares of the company's stock valued at $57,382,000 after acquiring an additional 930,701 shares in the last quarter. Finally, Northern Trust Corp boosted its holdings in shares of Haleon by 27.7% in the fourth quarter. Northern Trust Corp now owns 5,412,542 shares of the company's stock valued at $51,636,000 after acquiring an additional 1,172,931 shares in the last quarter. 6.67% of the stock is currently owned by institutional investors.

Haleon Trading Up 0.3%

Haleon stock traded up $0.03 during midday trading on Friday, reaching $11.36. The stock had a trading volume of 24,804,983 shares, compared to its average volume of 8,507,985. The firm's fifty day simple moving average is $10.40 and its two-hundred day simple moving average is $9.97. Haleon plc has a twelve month low of $8.25 and a twelve month high of $11.40. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.84 and a quick ratio of 0.58. The firm has a market cap of $51.17 billion, a price-to-earnings ratio of 33.41, a PEG ratio of 2.82 and a beta of 0.24.

Haleon (NYSE:HLN - Get Free Report) last posted its quarterly earnings data on Thursday, February 27th. The company reported $0.05 EPS for the quarter. Haleon had a net margin of 10.85% and a return on equity of 14.76%. The firm had revenue of $3.54 billion during the quarter, compared to analyst estimates of $3.38 billion. Equities analysts anticipate that Haleon plc will post 0.43 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on HLN shares. BNP Paribas upgraded shares of Haleon to a "strong-buy" rating in a report on Tuesday. HSBC restated a "hold" rating on shares of Haleon in a report on Wednesday, March 5th. Barclays restated an "overweight" rating on shares of Haleon in a report on Tuesday, May 6th. Deutsche Bank Aktiengesellschaft restated a "hold" rating on shares of Haleon in a report on Monday, March 3rd. Finally, Hsbc Global Res cut shares of Haleon from a "strong-buy" rating to a "hold" rating in a report on Wednesday, March 5th. Six equities research analysts have rated the stock with a hold rating, four have assigned a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $12.33.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.